相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice
Zhou Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
Patricia McGettigan et al.
PLOS MEDICINE (2011)
Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
Tilo Grosser et al.
ANNUAL REVIEW OF MEDICINE (2010)
Cyclooxygenase-2-Dependent Prostacyclin Formation and Blood Pressure Homeostasis Targeted Exchange of Cyclooxygenase Isoforms in Mice
Ying Yu et al.
CIRCULATION RESEARCH (2010)
Do the Blood Pressure Effects of Nonsteroidal Antiinflammatory Drugs Influence Cardiovascular Morbidity and Mortality?
William J. Elliott
CURRENT HYPERTENSION REPORTS (2010)
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function
Dairong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Endothelial S100A1 modulates vascular function via nitric oxide
Sven T. Pleger et al.
CIRCULATION RESEARCH (2008)
COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs
Timothy D. Warner et al.
LANCET (2008)
COX-2 in play at the AHA and the FDA
Garret A. FitzGerald
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Balancing prostanoid activity in the human vascular system
Nicholas A. Flavahan
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events
Jane A. Mitchell et al.
FASEB JOURNAL (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
Y Cheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22α-Cre transgenic mice
JJ Lepore et al.
GENESIS (2005)
Restricted inactivation of serum response factor to the cardiovascular system
JM Miano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II (vol 110, pg 61, 2002)
ZH Qi et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Opposite effects of cyclooxygenase-1 and-2 activity on the pressor response to angiotensin II
ZH Qi et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Role of prostacyclin in the cardiovascular response to thromboxane A2
Y Cheng et al.
SCIENCE (2002)
Tie2-Cre transgenic mice:: A new model for endothelial cell-lineage analysis in vivo
YY Kisanuki et al.
DEVELOPMENTAL BIOLOGY (2001)
分享论文
